The team at Device Access are delighted to announce that Dr Christopher Pomfrett has accepted the position of MedTech Evidence and Technical Director at Device Access UK effective as of the 2nd of February.
In this new position, Dr Pomfrett, who is a registered Clinical Scientist, will be responsible for advising Device Access clients on the importance of relevant claims of evidence for Health Technology Assessment, and for NHS Commissioning and funding.
In Dr Pomfrett’s previous 11-year tenure at The National Institute for Health & Care Excellence (NICE), he advised companies on how to address evidence gaps and commission new evidence, especially for those specific technologies that were recommended for further research during NICE Medical Technologies evaluation. In addition, Dr Pomfrett advised the NICE Medical Technologies Advisory Committee (MTAC) on research recommendations.
He has published over 80 communications in peer reviewed journals, including 3 full papers describing the work of NICE.
Dr Pomfrett was the former President of the Section of Anaesthesia (2014-2016), Royal Society of Medicine.
Dr Pomfrett said “As a past medical device inventor and adviser at NICE, I am very aware of the need for timely, robust, and appropriate evidence to support device access to the NHS. Device Access UK have the experience and resources to facilitate such evidence generation, especially where transformational change is happening in established and emerging clinical fields, including AI, digital, and human factors.”
Michael Branagan-Harris, Founder and CEO of Device Access UK said “Since 2010 the Device Access team has been focussed on getting great technologies to patients faster. The importance of our MedTech clients gaining the right clinical and economic evidence to support their claims has never been more important, especially at a time when the NHS needs technological solutions, with such a backlog of waiting list patients due to Covid 19.
We are delighted to welcome Chris with his extensive and highly relevant experience to the team, and for us to continue to offer the very best advice to our customers, as we continue to help drive great technologies into the NHS, that benefit patients, care providers and payers”.